{
  "id": 14552283,
  "title": "SOLVE FSHD Portfolio Company Altay Therapeutics Closes $37 Million Series A Financing to Advance DX5057 for FSHD",
  "url": "https://urgent.news/2026/10/14/solve-fshd-portfolio-company-altay-therapeutics-closes-37-million",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-14T22:27:48.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/pmn/business-wire-news-releases-pmn/solve-fshd-portfolio-company-altay-therapeutics-closes-37-million-series-a-financing-to-advance-dx5057-for-fshd"
  },
  "original_language": "en",
  "account": null,
  "summary": "Milestone follows nearly US$7 million in seed investment and strategic support from SOLVE FSHD VANCOUVER, British Columbia — SOLVE FSHD, a venture-philanthropy organization dedicated to accelerating therapies for facioscapulohumeral muscular dystrophy (FSHD), today celebrated the closing of a US$37 million Series A financing by portfolio company Altay Therapeutics, Inc. The financing was co-led…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}